Please login to the form below
Advent
This page shows the latest Advent news and features for those working in and with pharma, biotech and healthcare.
Gottlieb admonishes industry for clinical trial failings
Gottlieb – who is leaving the FDA next month and will be replaced on an interim basis by National Cancer Institute (NCI) director Ned Sharpless – says that the advent in precision medicine,
Latest news
-
Pfizer’s flat sales focus investor attention on M&A
In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
-
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out of a
-
Sanofi sells European generics to Advent for $2.4bn
The deal will create a new, independent European generics company. Private equity group Advent has agreed a 1.9bn ($2.4bn) deal to buy the European generics unit of French pharma ... Sanofi has been looking to divest the Zentiva generics unit since 2016
-
Time running out on new Stada takeover bid
That offer beat out a rival overture from Advent and Permira.
-
Trouble at the top of Stada as Bain and Cinven mull fresh bid
Their offer beat out another bid from Advent and Permira.
More from news
Approximately 3 fully matching, plus 92 partially matching documents found.
Latest Intelligence
-
Immunotherapy combination trials Q&A
Finally the advent of precision medicine platforms that deploy natural language processing algorithms to interrogate Electronic Health Records in defined site networks is assisting sites to know their patient populations better ... With the advent of the
-
Behaviour change: what is the buzz all about?
The advent of the ‘informed patient’ for whom social media, in particular, has provided a voice, means that patients have become more central – a positive trend that looks set to increase
-
Cancer care – the power of new technologies
Generally, new medicines and treatment approaches are offering renewed hope for cancer patients and the advent of innovative digital technologies is starting to disrupt clinical practice, presenting new ways of driving
-
Reaching the new influencers
Right now, we’re living through healthcare’s age of accelerations - as evidenced by advances in everything from biotechnology and stem cell research to machine learning and the advent (and approvals)
-
Cancer in The Information Age: are we illuminated or inundated?
Personalised vs personal medicine. Data and information have already proved fruitful in the clinic, yielding the advent of personalised cancer medicine,.
More from intelligence
Approximately 0 fully matching, plus 30 partially matching documents found.
Latest from PMHub
-
SWITCHED ONcology Patient Experience Focus Group Full Discussion
The focus group provided deeper insight in to a number of themes including the transformation of cancer understanding, the barriers to cancer diagnosis, the advent of new treatments including immunotherapy, communication
-
Training the next generation of biotech leaders
With the advent of personalised medicine, biotechs and academia are focusing their efforts on ensuring the manufacturing process can be both scaled up and reproduced.
-
Data Visualisation in Medical Communication
The advent of big data means that we now have access to unprecedented volumes of data, but we need tools to process and understand it.
-
Marketing strategy in complex environments
One example of this is in cystic fibrosis, and the advent of disease modifying agents specific towards certain genetic mutations ( Kalydeco, Orkambi).
-
A view from within #LucidLife
The advent of a significant birthday is an opportunity for reflection, and so I’ve been considering the journey that Lucid and I have been on. Lucid has always adopted a
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Health Consultant - Brand Comms
-
Competitive Salary
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Scientific Director – Medical Communications
-
Salary TBC
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Account Director, Medical Education
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Senior Account Manager, Medical Communications, London
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
- Fishawack acquires Dudnyk
- GSK’s myeloma drug hits target, prompting rapid filing pledge
- Winners of the HSJ Partnership Awards 2019 unveiled
- 50 questions for delivering an exceptional healthcare brand experience
- Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity
- The brand strategy revolution
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- 50 questions for delivering an exceptional healthcare brand experience
- Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
- The brand strategy revolution
- Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
